The 6-methyladenine (m6A) modification plays a major role in various diseases. Serine protease 8 (Prss8) contributes to the initiation and progression of liver fibrosis (LF). However, the mechanism by which the m6A modification of Prss8 induces hepatic stellate cells (HSCs) activation in the LF is unclear. This study focused on exploring the contribution of Prss8 m6A modification to the pathogenesis of LF. First, primary hepatic parenchymal cells (hepatocytes) and HSCs were isolated from a mouse model of LF, and a coculture of these two types of cells was used as the object of study. Then, real-time fluorescence quantitative PCR, methylated RNA immunoprecipitation, and Western blotting were used to test the expression levels of Prss8 mRNA and protein, Prss8 m6A modification, Collagen I, α-SMA, and TLR4. Finally, the expression levels of inflammatory markers were measured via an enzyme-linked immunosorbent assay. Compared with the control group, the model group presented significantly lower Prss8 mRNA and protein levels in hepatocytes but greater levels of Prss8 m6A modification; moreover, the expression of HSC activation markers and the TLR4, IL-1β, and IL-18 proteins was significantly elevated. Mutation of the Prss8 m6A modification site led to upregulation of Prss8 mRNA and protein and decreased levels of m6A modification, TLR4, IL-1β, and IL-18. Furthermore, mutation of the Prss8 m6A modification site increased the stability of Prss8 mRNA. Rescue experiments confirmed the regulatory link between Prss8 m6A modification and TLR4. Overall, Prss8 m6A modification decreases the stability of its mRNA, promoting TLR4-mediated inflammatory cascades and leading to excessive activation of HSCs. Targeting Prss8 m6A modification is a promising therapeutic strategy for LF.
Get full access to this article
View all access options for this article.
References
1.
AlqahtaniSA, SchattenbergJM. NAFLD in the elderly. Clin Interv Aging, 2021; 16:1633–1649; doi: 10.2147/cia.S295524
2.
BianZL, MiaoQ, ZhongW, et al.Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease. J Autoimmun, 2015; 63:76–87; doi: 10.1016/j.jaut.2015.07.010
CharanHV, DwivediDK, KhanS, et al.Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis. Genes Dis, 2023; 10(2):480–494; doi: 10.1016/j.gendis.2021.12.006
5.
ChenL, XiaS, WangF, et al.m(6)a methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. Pharmacol Res, 2023; 189:106704; doi: 10.1016/j.phrs.2023.106704
6.
ChenYH, WuZF, YuanBY, et al.MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway. Cell Death Dis, 2018; 9(2):22; doi: 10.1038/s41419-017-0038-z
DemelUM, LutzR, SujerS, et al.A complex proinflammatory Cascade mediates the activation of HSCs upon LPS exposure in vivo. Blood Adv, 2022; 6(11):3513–3528; doi: 10.1182/bloodadvances.2021006088
9.
DongBN, ZhouY, WangW, et al.Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology, 2020; 71(5):1559–1574; doi: 10.1002/hep.30937
10.
FanC, MaY, ChenS, et al.Comprehensive analysis of the transcriptome-Wide m6A methylation modification difference in liver fibrosis mice by high-Throughput m6A sequencing. Front Cell Dev Biol, 2021; 9:767051; doi: 10.3389/fcell.2021.767051
11.
FanJF, TongGZ, ChenXX, et al.CK2 blockade alleviates liver fibrosis by suppressing activation of hepatic stellate cells via the hedgehog pathway. Br J Pharmacol, 2023; 180(1):44–61; doi: 10.1111/bph.15945
12.
FarrellGC, HaczeyniF, ChitturiS, et al..Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. Springer-Verlag Singapore Pte Ltd.: Singapore; 2018.
13.
FlaminiS, SergeevP, de BarrosZV, et al.Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis, 2021; 12(5):421; doi: 10.1038/s41419-021-03704-w
14.
GaoL, LiPY, TianHJ, et al.Screening of biomarkers involved in idiopathic pulmonary fibrosis and regulation of upstream miRNAs. Am J Med Sci, 2022; 363(1):55–63.
15.
Hernandez-GeaV, FriedmanSL, AbbasAK, et al.Pathogenesis of Liver Fibrosis. Palo Alto: Annual Reviews; 2011.
16.
HuangT, ShangZ, NieL, et al.m6A modified ATG9A is required in regulating autophagy to promote HSCs activation and liver fibrosis. Cell Signal, 2025; 127:111619; doi: 10.1016/j.cellsig.2025.111619
17.
JiangH, QinXJ, LiWP, et al.Effects of shu gan jian Pi formula on rats with carbon tetrachloride-induced liver fibrosis using serum metabonomics based on gas chromatography-time of flight mass spectrometry. Mol Med Rep, 2017; 16(4):3901–3909; doi: 10.3892/mmr.2017.7078
18.
KarthiyaR, KhandeliaP. m6A RNA methylation: Ramifications for gene expression and human health. Mol Biotechnol, 2020; 62(10):467–484; doi: 10.1007/s12033-020-00269-5
19.
LiHL, LiT, ChenZQ, et al.Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway. Korean J Physiol Pharmacol, 2022; 26(5):335–345; doi: 10.4196/kjpp.2022.26.5.335
20.
LiJ, ZhaoYR, TianZ. Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis. World J Hepatol, 2019; 11(5):412–420; doi: 10.4254/wjh.v11.i5.412
21.
LiZ, MaY, FanC, et al.The circAno6/miR-296-3p/TLR4 signaling axis mediates the inflammatory response to induce the activation of hepatic stellate cells. Gene, 2024; 920:148497; doi: 10.1016/j.gene.2024.148497
22.
LiZ, ZhangC, HuangG, et al.Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10. Cell Death Dis, 2025; 16(1):245; doi: 10.1038/s41419-025-07500-8
23.
LiuP, QianYR, LiuX, et al.Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis. Front Immunol, 2023; 13(10):1096402; doi: 10.3389/fimmu.2022.1096402
24.
LiuQ, LeiXH, CaoZY, et al.TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell Biosci, 2022; 12(1):58; doi: 10.1186/s13578-022-00789-4
25.
LiuX, HuH, YinJQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int, 2006; 26(1):8–22; doi: 10.1111/j.1478-3231.2005.01192.x
26.
LiuZG, ZhuPT, ZhangL, et al.Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis. Biomed Pharmacother, 2018; 103:1262–1271; doi: 10.1016/j.biopha.2018.04.156
27.
MafandaEK, KandhiR, BobbalaD, et al.Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. Cytokine, 2019; 124:154501; doi: 10.1016/j.cyto.2018.07.032
28.
NiY, LiJM, LiuMK, et al.Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol, 2017; 23(43):7666–7677; doi: 10.3748/wjg.v23.i43.7666
29.
NicotraL, LoramLC, WatkinsLR, et al.Toll-like receptors in chronic pain. Exp Neurol, 2012; 234(2):316–329; doi: 10.1016/j.expneurol.2011.09.038
30.
SugitaniY, NishidaA, InatomiO, et al.Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease. J Gastroenterol, 2020; 55(4):408–417; doi: 10.1007/s00535-019-01660-z
TsengYJ, DongL, LiuYF, et al.Role of autophagy in chronic liver inflammation and fibrosis. Curr Protein Pept Sci, 2019; 20(8):817–822; doi: 10.2174/1389203720666190305165203
WangJF, DuM, MengLD, et al.Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1. Hepatol Commun, 2023; 7(1):e0004; doi: 10.1097/hc9.0000000000000004
35.
WeiA, ZhaoF, HaoA, et al.N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through hedgehog pathway. Gene, 2022; 813:146125; doi: 10.1016/j.gene.2021.146125
36.
WuF, ZhangLY, LaiCY, et al.Dynamic alteration profile and new role of RNA m6A methylation in replicative and H2O2-Induced premature senescence of human embryonic lung fibroblasts. Int J Mol Sci, 2022; 23(16):9271; doi: 10.3390/ijms23169271
37.
XuW, MoW, HanD, et al.Hepatocyte-derived exosomes deliver the lncRNA CYTOR to hepatic stellate cells and promote liver fibrosis. J Cell Mol Med, 2024; 28(8):e18234; doi: 10.1111/jcmm.18234
38.
ZengL, ChenY, WangY, et al.MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation. Biochem Pharmacol, 2017; 140:139–149; doi: 10.1016/j.bcp.2017.05.018
39.
ZhangCZ, HuangSZ, ZhuangHK, et al.YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene, 2020; 39(23):4507–4518; doi: 10.1038/s41388-020-1303-7
40.
ZhangJL, YangAH, WuY, et al.Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs system in rats. Biomed Pharmacother, 2018; 97:1586–1594; doi: 10.1016/j.biopha.2017.11.117
41.
ZhangL, JiaGZ, ShiBY, et al.PRSS8 is downregulated and suppresses tumour growth and metastases in hepatocellular carcinoma. Cell Physiol Biochem, 2016; 40(3–4):757–769; doi: 10.1159/000453136
42.
ZhangT, MaC, ZhangZ, et al.NF-κB signaling in inflammation and cancer. MedComm (2020), 2021; 2(4):618–653; doi: 10.1002/mco2.104
43.
ZhangY, GaoLX, WangW, et al.M(6) a demethylase fat mass and obesity-associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1. Cancer Sci, 2022; 113(9):3085–3096; doi: 10.1111/cas.15469
44.
ZhaoT, QiJ, LiuT, et al.N6-Methyladenosine modification participates in the progression of hepatitis B virus-related liver fibrosis by regulating immune cell infiltration. Front Med (Lausanne), 2022; 9:821710; doi: 10.3389/fmed.2022.821710
45.
ZhouMY, ChengML, HuangT, et al.Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells. World J Gastroenterol, 2021; 27(40):6908–6926; doi: 10.3748/wjg.v27.i40.6908
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
